Merck to Showcase Advances in the Science of Cancer With New Data Presented at ASCO 2024
资讯
2024-05-24
First-in-human data for potential first-in-class anti-CEACAM5 ADC with topoisomerase 1 inhibitor payload, M9140, in treatment of metastatic colorectal cancer to be featured in oral presentation
Ph...